Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04068480Recruiting

Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy

Role: lead

NCT03562572Not ApplicableActive Not Recruiting

FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

Role: collaborator

NCT04792255Not ApplicableUnknown

Digital Variance Angiography for Contrast Media Dose Reduction in Carotid Artery Stenting

Role: collaborator

NCT03234725Completed

Analysis of New Endoscopic Features and Variable Stiffness in Colonoscopy: Prospective Randomised Trial

Role: lead

All 4 trials loaded